Mood stabilizers in the prevention of recurrent affective disorders: A meta-analysis

Acta Psychiatrica Scandinavica

Volumn 100, Issue 6, 1999, Pages 406-417

  Davis, John M ^a   Janicak, P G ^a   Hogan, D M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Affective disorders; Drug withdrawal symptoms; Lithium bipolar disorder; Meta analysis

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

AFFECTIVE NEUROSIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REVIEW;

EID: 0032715803     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb10890.x     Document Type: Review

References (94)

1. BLACKWELL B, SHEPHERD M. Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet 1968;1:968-971.
2. BLACKWELL B. Need for careful evaluation of lithium. Am J Psychiatry 1969;125:1131.
3. DICKSON WE, KENDELL RE. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol Med 1986;16:521-530.
4. MANDER AJ. Is there a lithium withdrawal syndrome? Br J Psychiatry 1986;149:498-501.
5. MANNER AJ. Clinical prediction of outcome and lithium response in bipolar affective disorder. J Affect Disord 1986;11:35-41.
6. MARKAR HR, MANDER AJ. Efficacy of lithium prophylaxis in clinical practice [see comments]. Br J Psychiatry 1989;155:496-500.
7. MONCRIEFF J. Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder [editorial] [see comments]. Br J Psychiatry 1995;167:569-573.
8. MONCRIEFF J. Forty years of lithium treatment [letter; comment]. Arch Gen Psychiatry 1998;55:92-93.
9. MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 1959;22:719-748.
10. PETO R, PIKE MC, ARMITAGE P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
11. HEDGES LV, OLKIN I. Statistical methods for meta-analysis. Orlando, FL: Academic Press, 1985.
12. GIBBONS RD, HEDEKER DR, DAVIS JM. Estimation of effect size from a series of experiments involving paired comparisons. J Edu Stat 1993;18:271-279.
13. COPPEN A, ABOU-SALEH M, MILLN P, BAILEY J, WOOD K. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J Affect Disord 1983;5:353-362.
14. POOLE AJ, JAMES HD, HUGHES WC. Treatment experiences in the lithium clinic at St Thomas Hospital. J R Soc Med 1978;71:890-894.
15. MAJ M, PIROZZI R, KEMALI D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology 1989;98:535-538.
16. PAGE C, BENAIM S, LAPPIN F. A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate. Br J Psychiatry 1987;150:175-179.
17. NAYLOR GJ, DONALD JM, LE POIDEVIN D, REID AH. A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry 1974;124:52-57.
18. GRAM LF, RAFAELSEN OJ. Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatr Scand 1972;48:253-260.
19. COPPEN A, STANDISH-BARRY H, BAILEY J, HOUSTON G, SILCOCKS P, HERMON C. Long-term lithium and mortality [letter]. Lancet 1990;335:1347.
20. COPPEN A, STANDISH-BARRY H, BAILEY J, HOUSTON G, SILCOCKS P, HERMON C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991;23:1-7.
21. AHRENS B, MÜLLER-OERLINGHAUSEN B, SCHOU M et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995;33:67-75.
22. LENZ G, KRANKENHAUS A. Increased mortality after dropout from lithium clinic. Neuropsychopharmacology 1994;682S.
23. MÜLLER-OERLINGHAUSEN B, AHRENS B, VOLK J et al. Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI [letter]. Psychiatry Res 1991;36:329-331.
24. MÜLLER-OERLINGHAUSEN B, AHRENS B, GROF E et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-222.
25. MÜLLER-OERLINGHAUSEN B, WOLF T, AHRENS B et al. Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-Treated Patients. Acta Psychiatr Scand 1994;90:295-297.
26. NILSSON A. Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry 1995;28:8-13.
27. WOLF T, MÜLLER-OERLINGHAUSEN B, AHRENS B et al. How to interpret findings on mortality of long-term lithium-treated manic-depressive patients?! Critique of different methodological approaches. J Affect Disord 1996;39:127-132.
28. SCHOU M. The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians. J Affect Disord 1998;50:253-259.
29. MÜLLER-OERLINGHAUSEN B, WOLF T, AHRENS B et al. Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI). Acta Psychiatr Scand 1996;94:344-347.
30. TONDO L, BALDESSARINI RJ, HENNEN J, FLORIS G, SILVETTI F, TOHEN M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405-414.
31. BOCCHETA A, ARDAU R, BURRAI C, CHILLOTTI C, QUESADA G, DEL ZOMPO M. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J Clin Psychopharmacol 1998;18:384-389.
32. COPPEN A, FARMER R. Suicide mortality in patients on lithium maintenance therapy [In Process Citation]. J Affect Disord 1998;50:261-267.
33. KLOSIEWICZ L. Preventive effect of valproic acid amide in affective diseases. Psychiatr Pol 1985;19:23-29.
34. EMRICH HM, WOLF R. Valproate treatment of mania. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:691-701.
35. PUZYNSKI S, KLOSIEWICZ L. Valproic acid amide in the treatment of affective and schizoaffective disorders. J Affect Disord 1984;6:115-121.
36. KING JR, HULLIN RP. Withdrawal symptoms from lithium. Four case reports and a questionnaire study. Br J Psychiatry 1983;143:30-35.
37. GREIL W, BROUCEK B, KLEIN HE, ENGEL-SITTENFELD P. Discontinuation of lithium maintenance therapy; reversibility of clinical, psychological and neuroendocrinological changes. In: EMRICH, HM, ALDENHOFF JB, LUX HD, ed. Basic mechanisms in the action of lithium. Amsterdam: Excerpta Medica, 1982:235-248.
38. BAASTRUP PC, SCHOU M. Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967;16:162-172.
39. GOODNICK PJ, FIEVE, RR, PESELOW E, SCHLEGEL A, FILIPPI A. General behavior inventory: measurement of subclinical changes during depression and lithium prophylaxis. Acta Psychiatr Scand 1986;73:529-532.
40. SCHOU M, BAASTRUP PC, GROF P, WEIS P, ANGST J. Pharmacological and clinical problems of lithium prophylaxis. Br J Psychiatry 1970;116:615-619.
41. GROF P, CAKULS P, DOSRAL T. Lithium drop-outs: a follow-up study of patients who discontinued prophylactic lithium treatment. Int Pharmacopsychiatry 1970;5:162-169.
42. SCHOU M. Lithium prophylaxis: about 'naturalistic' or 'clinical practic' studies. Lithium 1993;4:77-81.
43. SUPPES T, BALDESSARINI RJ, FAEDDA GL, TOHEN M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088.
44. FYRO B, PETERSON U. A double-blind study of the prophylactic effect of lithium in manic-depressive disease. Acta Psychiatr Scand 1977;269(Suppl.):17-22.
45. MARGO A, MCMAHON P. Lithium withdrawal triggers psychosis. Br J Psychiatry 1982;141:407-410.
46. SMALL JG, SMALL IF, MOORE DF. Experimental withdrawal of lithium in recovered manic-depressive patients: a report of five cases. Am J Psychiatry 1971;127:1555-1558.
47. POST RM, LEVERICH GS, ROSOFF AS, ALTSHULER LL. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up. J Clin Psychopharmacol 1990;10:318-327.
48. POST RM, LEVERICH GS, ALTSHULER L, MIKALAUSKAS K. Lithium-discontinuation-induced refractoriness: preliminary observations [see comments]. Am J Psychiatry 1992;149:1727-1729.
49. FAEDDA GL, TONDO L, BALDESSARINI RJ, SUPPES T, TOHEN M. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993;50:448-455.
50. HARROW M, GOLDBERG JF, GROSSMAN LS, MELTZER Hy. Outcome in manic disorders. A naturalistic follow-up study [see comments]. Arch Gen Psychiatry 1990;47:665-671.
51. COPPEN A, NOGUERA R, BAILEY J et al. Prophylactic lithium in affective disorders. Controlled trial. Lancet 1971;2:275-279.
52. BAASTRUP PC, POULSEN JC, SCHOU M, THOMSEN K, AMDISEN A. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-330.
53. PRIEN RF, KLETT CJ, CAFFEY EM JR. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420-425.
54. PRIEN RF, CAFFEY EM JR, KLETT CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1973;28:337-341.
55. POKORNY AD, PRIEN RF. Lithium in treatment and prevention of affective disorder. Dis Nerv Syst 1974;35:327-333.
56. MELIA PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621-624.
57. PERSSON G. Lithium prophylaxis in affective disorders. Acta Psychiatr Scand 1972;48:462-479.
58. BALDESSARINI RJ, TONDO L, VIGUERA AC. Forty years of lithium treatment [in reply]. Arch Gen Psychiatry 1998;55:93.
59. SCHOU M. Is there a lithium withdrawal syndrome? An examination of the evidence. Br J Psychiatry 1993;163:514-518.
60. LAVANTES B, SENIMON F, BAYLE FJ. [No title available]. Encephale 1999;25:152-157.
61. GOODWIN GM. Lithium revisited [a reply]. Br J Psychiatry 1995;167:573-574.
62. KANE JM, QUITKIN FM, RIEKIN A, RAMOS-LORENZI JR, NAYAK DD, HOWARD A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982;39:1065-1069.
63. FIEVE RR, KUMBARACI T, DUNNER DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976;133:925-929.
64. CUNDALL RL, BROOKS PW, MURRAY LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972;2:308-311.
65. MANDER AJ, LOUDON JB. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 1988;2:15-17.
66. CHRISTODOULOU GN, LYKOURAS EP. Abrupt lithium discontinuation in manic-depressive patients. Acta Psychiatr Scand 1982;65:310-314.
67. HANNA SM, JENNER FA, PEARSON IB, SAMPSON GA, THOMPSON EA. The therapeutic effect of lithium carbonate on a patient with a forty-eight-hour periodic psychosis. Br J Psychiatry 1972;121:271-280.
68. GLEN AI, JOHNSON AL, SHEPHERD M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med 1984;14:37-50.
69. HULLIN RP, MCDONALD R, ALLSOPP MN. Prophylactic lithium in recurrent affective disorders. Lancet 1972;1:1044-1046.
70. KLEIN HE, BROUCEK B, GREIL W. Lithium withdrawal triggers psychotic states [letter]. Br J Psychiatry 1981;139:255-256.
71. GELENBERG AJ, KANE JM, KELLER MB et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493.
72. WATERS B, LAPIERRE Y, GAGNON A et al. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol Psychiatry 1982;17:1323-1329.
73. HULLIN RP, MCDONALD R, ALLSOPP MN. Further report on prophylactic lithium in recurrent affective disorders. Br J Psychiatry 1975;126:281-284.
74. JERRAM TC, MCDONALD R. Plasma lithium control with particular reference to minimum effective levels. In: JOHNSON FN, JOHNSON S, ed. Lithium in medical practice. Lancaster: MTP Press, 1978.
75. MAJ M, STARACE F, NOLFE G, KEMALI D. Minimum plasma lithium levels required for effective prophylaxis in DSM-III bipolar disorder: a prospective study. Pharmacopsychiatry 1986;19:420-423.
76. HOLINGER PC, WOLPERT EA. A ten-year follow-up of lithium use. III Med J 1979;156:99-104.
77. BOUMAN TK, NIEMANTSVERDRIET-VAN KAMPEN JG, ORMEL J, SLOOFF CJ. The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizo-affective disorders. J Affect Disord 1986;11:275-280.
78. ANGST J, WEIS P, GROF P, BAASTRUP PC, SCHOU M. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970;116:604-614.
79. MAJ M, PIROZZI R, STARACE F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989;17:237-241.
80. MELIA PI. A pilot trial of lithium carbonate in recurrent affective disorders. J Br Med Assoc 1967;60:160-170.
81. KUKOPULOS A, REGINALDI D. Does lithium prevent depressions by suppressing manias? Int Pharmacopsychiatry 1973;8:152-158.
82. TONDO L, BALDESSARINI RJ, HENNEN J, FLORIS G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998;155:638-645.
83. LEPKIFKER E, HORESH N, FLORU S. Long-term lithium prophylaxis in recurrent unipolar depression. A controversial indication? Acta Psychiatr Belg 1985;85:434-443.
84. STANCER HC, FURLONG FW, GODSE DD. A longitudinal investigation of lithium as a prophylactic agent for recurrent depressions. Can Psychiatr Assoc J 1970;15:29-40.
85. PLACIDI GF, LENZI A, LAZZERINI F, CASSANO GB, AKISKAL HS. The comparative efficacy and safety of carbamaz-epine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-494.
86. WATKINS SE, CALLENDER K, THOMAS DR, TIDMARSH SF, SHAW DM. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987;150:180-182.
87. LUSZNAT RM, MURPHY DP, NUNN CM. Carbamazepine vs. lithium in the treatment and prophylaxis of mania [see comments]. Br J Psychiatry 1988;153:198-204.
88. STOLL KD, CONCALVES N, KROBER HL, DEMISCH K, BELLAIRE W. Use of carbamazepine in affective illness. In: LERER G, GERSHON S, ed. New directions in affective disorders. New York: Springer-Verlag, 1989;540-544.
89. CABRERA JF, MÜHLBAUER HD, SCHLEY J, STOLL, KD, MÜLLER-OERLINGHAUSEN B. Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 1986;19:282-283.
90. SMALL JG, KLAPPER MH, MILSTEIN V et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991;48:915-921.
91. COXHEAD N, SILVERSTONE T, COOKSON J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992;85:114-118.
92. SIMHANDL C, DENK E, THAU K. The comparative efficacy of carbamazepine low and high serum levels and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 1993;28:221-231.
93. DENICOFF KD, SMITH-JACKSON EE, DISNEY ER, ALI SO, LEVERICH GS, POST RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-478.
94. GREIL W, LUDWIG-MAYERHOFER W, ERAZO N et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Disord 1997;43:151-161.